Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract 4559: Tumor-derived Galectin-1 promotes tumor growth in an orthotopic C57Bl/6 NB mouse model

Stefan Fest

Cancer Res (2019) 79 (13_Supplement): 4559.

https://doi.org/10.1158/1538-7445.AM2019-4559

Published: 01 July 2019

View article titled, Abstract 4559: Tumor-derived Galectin-1 promotes tumor growth in an orthotopic C57Bl/6 NB mouse model

Journal Articles

Abstract 4570: Selective depletion of regulatory T cells suppressed neuroblastoma tumor growth in mice

Sophie von Lenthe, Christine Weißenborn, Ana Claudia Zenclussen, Stefan Fest, Leonid Metelitsa

Cancer Res (2019) 79 (13_Supplement): 4570.

https://doi.org/10.1158/1538-7445.AM2019-4570

Published: 01 July 2019

View article titled, Abstract 4570: Selective depletion of regulatory T cells suppressed neuroblastoma tumor growth in mice

Journal Articles

Abstract 4758: A new syngeneic MYCN-overexpressing neuroblastoma mouse model and MYCN-DNA vaccine

Alexander Stermann, Nicole Huebener, Diana Seidel, Anastasia Shibina, Stefan Fest, Gerhard Gaedicke, Holger N. Lode

Cancer Res (2010) 70 (8_Supplement): 4758.

https://doi.org/10.1158/1538-7445.AM10-4758

Published: 15 April 2010

View article titled, Abstract 4758: A new syngeneic MYCN-overexpressing neuroblastoma mouse model and MYCN-DNA vaccine

Journal Articles

Survivin minigene DNA vaccination induces an effective CD8+ T cell response against neuroblastoma

Stefan Fest, Nicole Huebener, Matthias Bleeke, Tahir Durmus, Alexander Stermann, Ana Zenclussen, Elke Michalsky, Ines Jaeger, Gerhard Gaedicke, Ralph Reisfeld, Holger Lode

Cancer Res (2008) 68 (9_Supplement): 2867.

Published: 01 May 2008

View article titled, Survivin minigene DNA vaccination induces an effective CD8+ T cell response against neuroblastoma

Journal Articles

Xenogeneic immunization with a human tyrosine hydroxylase DNA vaccine effectively eradicates established neuroblastoma and induces long lasting protective immunity in mice

Nicole Huebener, Stefan Fest, Anja Woehler, Alexander Stermann, Bianca Baykan, Gerhard Gaedicke, Holger Lode

Cancer Res (2008) 68 (9_Supplement): 5297.

Published: 01 May 2008

View article titled, Xenogeneic immunization with a human tyrosine hydroxylase DNA vaccine effectively eradicates established neuroblastoma and induces long lasting protective immunity in mice

Journal Articles

The development of a new murine MYCN-amplified neuroblastoma cell line

Alexander Stermann, Nicole Huebener, Stefan Fest, Anja Wohler, Bianca Baykan, Gerhard Geadicke, Holger Lode

Cancer Res (2008) 68 (9_Supplement): 1020.

Published: 01 May 2008

View article titled, The development of a new murine MYCN-amplified neuroblastoma cell line

Journal Articles

A novel legumain DNA vaccine effectively eradicates neuroblastoma and induces long-term survival in vivo

Anja Woehler, Nicole Huebener, Stefan Fest, Alexander Stermann, Gerhard Gaedicke, Holger N Lode

Cancer Res (2008) 68 (9_Supplement): 2868.

Published: 01 May 2008

View article titled, A novel legumain DNA vaccine effectively eradicates neuroblastoma and induces long-term survival in vivo

Journal Articles

Xenogeneic immunization with a human tyrosine hydroxylase DNA vaccine is effective against neuroblastoma in vivo

Nicole Huebener, Stefan Fest, Kerstin Hilt, Yan Zeng, Silke Weixler, Gerhard Gaedicke, Holger Lode

Cancer Res (2007) 67 (9_Supplement): 1887.

Published: 01 May 2007

View article titled, Xenogeneic immunization with a human tyrosine hydroxylase DNA vaccine is effective against neuroblastoma in vivo

Journal Articles

Fractalkine (CX3CL1) rich neuroblastoma microenvironments favor T-cell mediated eradication of metastases following targeted IL-2 immuncytokine therapy

Holger Lode, Yan Zeng, Nicole Huebener, Stefan Fest, Ulrike Schroeder, Silke Weixler, Alexander Schramm, Angelika Eggert, Gerhard Gaedicke

Cancer Res (2007) 67 (9_Supplement): 517.

Published: 01 May 2007

View article titled, Fractalkine (CX3CL1) rich neuroblastoma microenvironments favor T-cell mediated eradication of metastases following targeted IL-2 immuncytokine therapy

Journal Articles

Survivin minigene DNA vaccine is effective against neuroblastoma

Stefan Fest, Nicole Huebener, Matthias Bleeke, Alexander Stermann, Silke Weixler, Gerhard Gaedicke, Rong Xiang, Ralph Reisfeld, Holger Lode

Cancer Res (2007) 67 (9_Supplement): 1875.

Published: 01 May 2007

View article titled, Survivin minigene DNA vaccine is effective against neuroblastoma

Journal Articles

Mimotope optimization for GD2 directed anti-neuroblastoma immunotherapy

Matthias Bleeke, Stefan Fest, Nicole Huebener, Christiane Landgraf, Rudolf Volkmer, Gerhard Gaedicke, Elke Michalsky, Ines Jaeger, Robert Preissner, Holger Lode

Cancer Res (2007) 67 (9_Supplement): 5101.

Published: 01 May 2007

View article titled, Mimotope optimization for GD2 directed anti-neuroblastoma immunotherapy

Journal Articles

Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Yan Zeng, Nicole Huebener, Stefan Fest, Silke Weixler, Ulrike Schroeder, Gerhard Gaedicke, Rong Xiang, Alexander Schramm, Angelika Eggert, Ralph A. Reisfeld, Holger N. Lode

Cancer Res (2007) 67 (5): 2331–2338.

https://doi.org/10.1158/0008-5472.CAN-06-3041

Published: 01 March 2007

View article titled, Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Journal Articles

Characterization of GD2 Peptide Mimotope DNA Vaccines Effective against Spontaneous Neuroblastoma Metastases

Stefan Fest, Nicole Huebener, Silke Weixler, Matthias Bleeke, Yan Zeng, Anne Strandsby, Rudolf Volkmer-Engert, Christiane Landgraf, Gerhard Gaedicke, Angelika B. Riemer, Elke Michalsky, Ines S. Jaeger, Robert Preissner, Elisabeth Förster-Wald, Erika Jensen-Jarolim, Holger N. Lode

Cancer Res (2006) 66 (21): 10567–10575.

https://doi.org/10.1158/0008-5472.CAN-06-1158

Published: 01 November 2006

View article titled, Characterization of GD2 Peptide Mimotope DNA Vaccines Effective against Spontaneous Neuroblastoma Metastases

Journal Articles

Peptide mutation analysis results in potent GD2 mimotope peptides for DNA vaccination against neuroblastoma

Holger N. Lode, Mathias Bleeke, Stefan Fest, Nicole Huebener, Yan Zeng, Silke Weixler, Rudolf Volkmer, Elisabeth Förster-Waldl, Erika Jensen-Jarolim, Gerhard Gaedicke

Cancer Res (2006) 66 (8_Supplement): 332.

Published: 15 April 2006

View article titled, Peptide mutation analysis results in potent GD2 mimotope peptides for DNA vaccination against neuroblastoma

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 4559: Tumor-derived Galectin-1 promotes tumor growth in an orthotopic C57Bl/6 NB mouse model

Abstract 4570: Selective depletion of regulatory T cells suppressed neuroblastoma tumor growth in mice

Abstract 4758: A new syngeneic MYCN-overexpressing neuroblastoma mouse model and MYCN-DNA vaccine

Survivin minigene DNA vaccination induces an effective CD8+ T cell response against neuroblastoma

Xenogeneic immunization with a human tyrosine hydroxylase DNA vaccine effectively eradicates established neuroblastoma and induces long lasting protective immunity in mice

The development of a new murine MYCN-amplified neuroblastoma cell line

A novel legumain DNA vaccine effectively eradicates neuroblastoma and induces long-term survival in vivo

Xenogeneic immunization with a human tyrosine hydroxylase DNA vaccine is effective against neuroblastoma in vivo

Fractalkine (CX3CL1) rich neuroblastoma microenvironments favor T-cell mediated eradication of metastases following targeted IL-2 immuncytokine therapy

Survivin minigene DNA vaccine is effective against neuroblastoma

Mimotope optimization for GD2 directed anti-neuroblastoma immunotherapy

Fractalkine (CX3CL1)– and Interleukin-2–Enriched Neuroblastoma Microenvironment Induces Eradication of Metastases Mediated by T Cells and Natural Killer Cells

Characterization of GD2 Peptide Mimotope DNA Vaccines Effective against Spontaneous Neuroblastoma Metastases

Peptide mutation analysis results in potent GD2 mimotope peptides for DNA vaccination against neuroblastoma

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media